Rhabdomyolysis - NYSORA

Explore NYSORA knowledge base for free:

Table of Contents

Contributors

Rhabdomyolysis

Rhabdomyolysis

Learning objectives

  • Definition and signs and symptoms of rhabdomyolysis
  • Causes of rhabdomyolysis
  • Treament and anesthetic management of rhabdomyolysis

Definition and mechanisms

  • Rhabdomyolysis occurs when damaged skeletal muscle breaks down rapidly and releases its content in the bloodstream
  • Characterized by skeletal muscle disintegration and the release of myoglobin and other intercellular proteins and electrolytes into the circulation
  • Hyperkalemia, hyperuricemia, and hyperphosphatemia can all develop rapidly
  • This can lead to heart- or kidney failure and can even be fatal
  • Rhabdomyolysis ranges from an asymptomatic illness with elevation in the CK level to a life-threatening condition associated with extreme elevations in CK, electrolyte imbalances, acute kidney injury, and disseminated intravascular coagulation
  • Most often caused by direct traumatic injury, however, can also result from a wide array of other causes

Signs and symptoms

  • Muscle pains or cramps
  • Weakness
  • Swelling of affected muscles
  • Nausea and vomiting
  • Confusion 
  • Coma
  • Tea-colored urine due to the presence of myoglobin
  • Abdominal pain
  • Fever
  • Tachycardia
  • Arrhythmias
  • Hypotension and shock
  • Acute kidney injury

AKI and rhabdomyolysis

  • Myoglobin interacts with the Tamm-Horsfall protein in the renal tubules to form brown granular casts which lead to tubular obstruction
  • This process is favoured when the urine is acidic
  • The heme group of myoglobin could lead to lipid peroxidation
  • Myoglobin also scavenges nitrous oxide leading to renal vasoconstriction
  • Renal blood flow is furter reduced by hypovolemia, activation of the RAAS system and other vascular mediators

Complications

Causes

Risk factors

Endogenous Risks Exogenous Risks
Advanced age (> 80 years)
Small body frame and frailty
Multisystem disease
- Renal dysfunction
- Hepatic dysfunction
Thyroid disorders, especially Hypothyroidism
Hypertriglyceridemia
Metabolic muscle disease
- Carnitine palmitoyltransferase II deficiency
- McArdle disease
Myoadenylate deaminase deficiency
Alcohol consumption
Heavy exercise
Surgery with severe metabolic demands
Agents affecting the cytochrome P450 system, especially
- Fibrates
- Nicotinic acid
- Cyclosporine
- Azole antifungals
- Macrolide antibiotics
- HIV protease inhibitors
- Nefazodone
- Verapamil
- Amiodarone
- Warfarin
- Consumption of > 1 quart daily of grapefruit juice

Diagnosis

  • Blood test: creatine kinase (CK) > 5000 U/L
    • Note that myoglobin levels peak before increases in CK
    • However, myoglobin is metabolized rapidly at sites outside of the kidney
    •  This makes CK a more reliable marker of rhabdomyolysis
InvestigationsPossible findings
Serum and urine myoglobinPresent
Urinary dipstick + pHPositive for blood
Urea and creatinineRaised
PotassiumRaised
CalciumLow
Phosphate, uric acidRaised
Coagulation studiesPrologend in severe cases
Blood gasLactic acidosis
Calculation of anion gapRaised
ECGPrologend in severe cases
  • A metabolic acidosis with a high anion gap is commonly reported in rhabdomyolysis with associated AKI

Management

Rhabdomyolysis, hypovolemia, fluid resuscitation, acute kidney injury, myoglobin, hyperkalemia, mannitol, compartment syndrome, succinylcholine

Suggested reading

  • Floridis, J., Barbour, R., 2022. Postoperative weakness and anesthetic-associated rhabdomyolysis in a pediatric patient: a case report and review of the literature. Journal of Medical Case Reports 16.
  • Pollard BJ, Kitchen, G. Handbook of Clinical Anaesthesia. Fourth Edition. CRC Press. 2018. 978-1-4987-6289-2.
  • Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J. 2015;15(1):58-69.
  • Williams J, Thrope C. 2014. Rhabdomyolysis. Continuing Education in Anaesthesia Critical Care & Pain. 14;4:163-166.
  • Hunter JD, Greggg K, Damani S. 2006. Rhabdomyolysis. Continuing Education in Anaesthesia Critical Care. 6;4:141-143.

We would love to hear from you. If you should detect any errors, email us customerservice@nysora.com

Upcoming Events View All